11-372211-C-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_178537.5(B4GALNT4):​c.254C>A​(p.Ala85Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000114 in 1,397,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 18/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A85V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

B4GALNT4
NM_178537.5 missense, splice_region

Scores

19
Splicing: ADA: 0.0001830
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -4.02

Publications

1 publications found
Variant links:
Genes affected
B4GALNT4 (HGNC:26315): (beta-1,4-N-acetyl-galactosaminyltransferase 4) Enables acetylgalactosaminyltransferase activity. Predicted to be located in Golgi cisterna membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05503297).
BS2
High AC in GnomAdExome4 at 16 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
B4GALNT4NM_178537.5 linkc.254C>A p.Ala85Glu missense_variant, splice_region_variant Exon 2 of 20 ENST00000329962.11 NP_848632.2 Q76KP1
B4GALNT4XM_017017654.2 linkc.-23C>A splice_region_variant Exon 2 of 20 XP_016873143.1
B4GALNT4XR_001747858.2 linkn.559C>A splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 18
B4GALNT4XM_017017654.2 linkc.-23C>A 5_prime_UTR_variant Exon 2 of 20 XP_016873143.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
B4GALNT4ENST00000329962.11 linkc.254C>A p.Ala85Glu missense_variant, splice_region_variant Exon 2 of 20 1 NM_178537.5 ENSP00000328277.6 Q76KP1
B4GALNT4ENST00000530717.1 linkn.262C>A splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 3 3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.0000114
AC:
16
AN:
1397546
Hom.:
0
Cov.:
33
AF XY:
0.0000102
AC XY:
7
AN XY:
689262
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31586
American (AMR)
AF:
0.00
AC:
0
AN:
35688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25170
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35726
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79206
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47922
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.0000148
AC:
16
AN:
1078576
Other (OTH)
AF:
0.00
AC:
0
AN:
57976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 25, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.254C>A (p.A85E) alteration is located in exon 2 (coding exon 2) of the B4GALNT4 gene. This alteration results from a C to A substitution at nucleotide position 254, causing the alanine (A) at amino acid position 85 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.014
DANN
Benign
0.87
DEOGEN2
Benign
0.00099
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.32
T
M_CAP
Benign
0.032
D
MetaRNN
Benign
0.055
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.6
L
PhyloP100
-4.0
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.033
Sift
Benign
0.34
T
Sift4G
Benign
0.29
T
Polyphen
0.20
B
Vest4
0.18
MutPred
0.11
Gain of relative solvent accessibility (P = 0.0507);
MVP
0.12
MPC
0.95
ClinPred
0.22
T
GERP RS
-3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.086
gMVP
0.35
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00018
dbscSNV1_RF
Benign
0.23
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747752780; hg19: chr11-372211; API